GENSCRIPT BIO(01548): CARVYKTI generated net trade sales of approximately US$710 million for the quarter ended September 30, 2026

20:37 13/10/2026

GENSCRIPT BIO (01548) announced that, pursuant to the Collaboration and License Agreement entered into on December 21, 2017 between Legend Biotech Corporation (an associate of the Company, whose shares are listed on the Nasdaq Global Select Market in the form of American Depositary Shares) and Janssen Biotech, Inc. (Janssen), CARVYKTI generated net trade sales of approximately US$710 million for the quarter ended September 30, 2026.

GENSCRIPT BIO(01548) announced that, pursuant to the Collaboration and License Agreement entered into on December 21, 2017 between Legend Biotech Corporation (an associate of the Company, whose shares are listed on the Nasdaq Global Select Market in the form of American Depositary Shares) and Janssen Biotech, Inc. (Janssen), CARVYKTI generated net trade sales of approximately US$710 million for the quarter ended September 30, 2026.

A-share IPO | Water purification component supplier Yuanda Jianke (920285.BJ) opens subscription, multiple products consistently rank on Amazon's best-selling lists for water filtration and pool filter cartridges.

Slender West Lake Cultural Tourism (06157) is conducting its public offering from October 14 to October 20, and plans to offer 44.76 million H shares globally.

DUIBA (01753): Expected that the AI short drama business will achieve net profit for three consecutive months in July, August, and September 2026.

Slender West Lake Cultural Tourism (06157) is conducting its public offering from October 14 to October 20, and plans to offer 44.76 million H shares globally.

DUIBA (01753): Expected that the AI short drama business will achieve net profit for three consecutive months in July, August, and September 2026.